Latest news
Epcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 15:39:51 GMTHER2-Targeted Regimen Yields High Pathologic Complete Response Rate in Locally Advanced Breast Cancer - The ASCO PostThe ASCO Post · Thu, 06 Aug 2026 13:47:28 GMTDocirbrutinib Yields High Response Rates in MCL and CLL - onclive.comonclive.com · Wed, 05 Aug 2026 15:26:11 GMTKura Oncology Reports 50% Response Rate in RCC Combination Study - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMT